Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic Business Environment Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic Jannie Delucca July 13, 2021 0 NTCD-M3 is being developed to battle Clostridioides difficile bacterial infections (CDI) in the gut () explained it... Read More Read more about Destiny Pharma PLC teams up with US Department of Veterans Affairs to find ‘new attributes’ for its next-generation antibiotic
